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Abstract
Background: Since 2003 Thailand has waged an aggressive "war on drugs" campaign focused on
arresting and incarcerating suspected drug users and dealers. However, little is known about
incarceration experiences among IDU in the wake of the recent war on drugs. Therefore, we
sought to examine incarceration experiences among IDU in Bangkok, Thailand.
Methods:  We examined the prevalence of incarceration among community-recruited IDU
participating in the Mitsampan Community Research Project. Multivariate logistic regression was
used to identify factors associated with a self-reported history of incarceration. We also examined
the prevalence of injection drug use and syringe sharing within prisons.
Results: 252 IDU were recruited in August 2008; 66 (26.2%) were female and the median age was
36.5 years. In total, 197 (78.2%) participants reported a history of incarceration. In multivariate
analyses, reporting a history of incarceration was associated with a history of compulsory drug
treatment (adjusted odds ratio [AOR] = 4.93; 95% confidence interval [CI]: 1.95 - 12.48), non-fatal
overdose (AOR = 3.69; 95%CI: 1.45 - 9.39), syringe sharing (AOR = 2.20; 95%CI: 1.12 - 4.32), and
female gender (AOR = 0.41; 95%CI: 0.20 - 0.82). Among those who reported a history of
incarceration, 59 (29.9%) reported injection drug use in prison, and 48 (81.4%) of these individuals
reported sharing syringes in prison. Incarceration was not associated with the number of injections
performed in the previous week (p = 0.202).
Conclusion: Over three-quarters of the IDU participating in this study reported a history of
incarceration, and 30% of these individuals reported injection drug use within prison. Further, an
alarmingly high level of syringe sharing within prison was reported, and incarceration was not
associated with reductions in drug use. These findings provide further evidence of the need for
community diversion strategies, as well as harm reduction programs, in Thai prisons.
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Background
In many countries, drug law enforcement continues to be
a dominant societal response to illicit drug use [1,2]. Con-
sequently, injection drug users (IDU) are frequently
arrested and incarcerated [3-5]. A large body of evidence
indicates that incarceration is associated with elevated
risks of drug-related harm among IDU, including the
spread of blood-borne pathogens such as human immun-
odeficiency virus (HIV) and hepatitis C virus (HCV) [6-
10]. For example, HIV outbreaks associated with injection
drug use in prison have been observed in Scotland [11],
Lithuania [12], and the Russian Federation [13]. Endemic
sharing of injection equipment has been identified as a
major factor contributing to high HCV incidence in pris-
ons in Australia [14] and Scotland [15]. The burden of
prison-related epidemics of infectious disease is essen-
tially linked with the public health of communities due to
high inmate turnover and the potential spread of prison-
acquired infections among non-inmate populations.
The first major wave of HIV infection in Thailand is
believed to have occurred among IDU inmates in Bang-
kok in 1988 [16]. Since then, several studies have sug-
gested that incarceration has continued to be an
important risk factor for HIV infection among Thai IDU
[17-21]. The HIV prevalence among Thai IDU remains
disproportionately high, standing between 30-50% [22-
24]. Moreover, a recent study reported an HIV/HCV co-
infection rate of 98.8% among HIV-positive IDU prison-
ers in Bangkok [25]. Despite these findings, Thailand has
consistently pursued an aggressive enforcement-based
response to illicit drug use [17,26,27]. The inmate popu-
lation in Thailand has more than tripled between 1992
and 2002, with approximately 70% of these incarceration
events attributable to drug-related charges [28,29].
The most aggressive "war on drugs" campaign in Thailand
was initiated in 2003 by the former Thai Prime Minister
Thaksin Shinawatra, which involved renewing and aug-
menting efforts to arrest and incarcerate suspected drug
users and dealers [26]. This campaign also involved dra-
matically scaling up compulsory addiction treatment pro-
gramming [30,31]. In 2008, the Thai government
reinstituted this policy initiative [32,33]. While epidemio-
logical evidence has linked incarceration with HIV infec-
tion among Thai IDU, little is known about rates of and
factors associated with incarceration among IDU in the
wake of these intensive law enforcement campaigns.
Therefore, we sought to characterize the prevalence and
correlates of incarceration among a community-recruited
sample of IDU in Bangkok, Thailand with the aim of
informing policies specific to addiction and public health.
Methods
Data for these analyses were obtained from the Mitsam-
pan Community Research Project, a collaborative research
effort involving the British Columbia Centre for Excel-
lence in HIV/AIDS (Vancouver, Canada), the Mitsampan
Harm Reduction Center (Bangkok, Thailand), the Thai
AIDS Treatment Action Group (Bangkok, Thailand), and
Chulalongkorn University (Bangkok, Thailand). During
July and August of 2008, the research partners designed
and undertook a cross-sectional study targeting local IDU
in Bangkok recruited through peer-based outreach efforts
and word-of-mouth. Invited participants were asked to
attend the Mitsampan Harm Reduction Center, where
they provided informed consent and completed an inter-
viewer-administered questionnaire. The survey instru-
ment elicited demographic data, information on drug use
patterns, HIV risk behavior, overdose experiences, interac-
tions with the criminal justice system (including police
and incarceration), and experience with health care. Upon
completion of the questionnaire, participants were pro-
vided a stipend of 250 Thai baht (about US$7.50) and
reimbursed for transportation costs. The study has been
approved by the research ethics boards at the University of
British Columbia and Chulalongkorn University.
The primary outcome of interest in the present analysis
was self-reported history of incarceration (i.e., answering
"Yes" to the question: "Have you ever been in prison over-
night or longer?"). We compared IDU who reported a his-
tory of incarceration with those who did not using
univariate statistics and multivariate logistic regression.
Variables considered included: median age (< 36.5 years
vs. ≥ 36.5 years); gender; education level (≥ secondary
school vs. < secondary school); median daily expenses for
purchasing drugs (< 300 Thai baht per day vs. ≥ 300 Thai
baht per day); ever injected heroin; ever injected yaba
(methamphetamine); ever injected midazolam; ever
injected methadone; ever used drugs in combination; ever
shared syringes; ever experienced a non-fatal overdose;
ever involved in sex trade; ever in compulsory drug treat-
ment; and ever on methadone treatment. All behavioral
variables were coded as yes vs. no.
To examine the bivariate associations between each inde-
pendent variable and a history of incarceration, we used
the Pearson X2 test. Fisher's exact test was used when one
or more of the cells contained values less than or equal to
five. We then applied an a priori-defined statistical proto-
col that examined factors associated with a history of
incarceration by fitting a multivariate logistic regression
model that included all variables that were significantly
associated with history of incarceration at the p < 0.05
level in univariate analyses. Using Pearson's correlation
coefficient, we also assessed whether reporting a history of
incarceration was associated with reduced drug use (as
measured by the number of injections performed in the
previous week). All p-values were two-sided. In a sub-anal-
ysis, we also asked individuals reporting a history of incar-BMC Public Health 2009, 9:492 http://www.biomedcentral.com/1471-2458/9/492
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ceration if they had ever injected drugs and shared
syringes in prison.
Results
In total, 252 IDU were recruited in August 2008, of whom
66 (26.2%) were female. The median age was 36.5 years
(IQR: 31.0-46.0 years). The majority of our sample (n =
238; 94.4%) grew up in the Bangkok Metropolitan Area.
One hundred fifty-five (61.5%) individuals reported
injection heroin use and 86 (34.1%) reported injection
yaba and ice (i.e., methamphetamine) use at least daily in
the past six months. Less than half of the participants (n =
111; 44.0%) had ever received methadone treatment, and
116 (46.0%) received drug or alcohol treatment in the
past six months. In total, 197 (78.2%) participants
reported a history of incarceration.
Table 1 presents the univariate analyses of factors associ-
ated with reporting a history of incarceration. As shown,
reporting a history of incarceration was positively associ-
ated with having been in compulsory drug treatment
(odds ratio [OR] = 4.91, 95% confidence interval [CI]:
2.01-12.03), history of non-fatal overdose (OR = 4.40,
95%CI: 1.80-10.79), syringe sharing (OR = 2.44, 95%CI:
1.30-4.58), and midazolam injection (OR = 2.00, 95%CI:
1.08-3.69), and was negatively associated with female
gender (OR = 0.48, 95%CI: 0.25-0.91).
Table 2 presents the multivariate analyses of factors inde-
pendently associated with reporting a history of incarcer-
ation. As shown, reporting a history of incarceration was
independently and positively associated with having been
in compulsory drug treatment (adjusted odds ratio [AOR]
= 4.93, 95%CI: 1.95-12.48), ever overdosed (AOR = 3.69,
95%CI: 1.45-9.39), syringe sharing (AOR = 2.20, 95%CI:
1.12-4.32), and was negatively associated with female
gender (AOR = 0.41, 95%CI: 0.20-0.82). Among those
who reported a history of incarceration, 59 (29.9%)
reported injection drug use in prison and 48 (81.4%) of
these individuals reported sharing syringes in prison.
Reporting a history of incarceration was not associated
with the number of injections performed in the previous
week (p = 0.202).
Discussion
More than three-quarters of the community-recruited IDU
participating in this study reported a history of incarcera-
tion. In multivariate analyses, after adjustment for rele-
vant covariates, reporting a history of incarceration was
positively associated with a history of compulsory drug
treatment, syringe sharing and non-fatal overdose.
Females were less likely than males to have been incarcer-
ated. Among those reporting a history of incarceration,
30% reported injection drug use within prison. Further,
an alarmingly high level of syringe sharing (81.4%) was
reported among those who injected drugs while in prison.
Reporting a history of incarceration was not found to be
associated with reduced frequency of injection drug use.
Our findings are consistent with previous studies suggest-
ing that incarceration is very common among Thai IDU
[17], and that high levels of drug injection and syringe
sharing occur within prisons in this setting [17,34]. How-
ever, the proportion of Thai IDU with a history of incar-
ceration observed in this study is considerably higher than
the one observed by Beyrer et al. during the period 1999-
2000, who reported that 55% of IDU in Northern Thai-
land had a history of incarceration [17]. This increase in
the prevalence of incarceration among Thai IDU may be
attributable to differences in sample characteristics or geo-
graphic differences in drug law enforcement efforts
between Northern Thailand and Bangkok, or the higher
prevalence observed in our study may reflect the 2003 war
on drugs and subsequent crackdowns that have taken
place throughout the country in spite of policy efforts to
redirect people who use drugs to treatment centers rather
than prison. Regardless, given the high prevalence of HIV
infection in this setting [23,24] and the high levels of
injection drug use and syringe sharing that occur within
prisons, it is unlikely that the epidemic of HIV among
Thai IDU can be controlled under the current enforce-
ment-based policy approach. As has been suggested previ-
ously [35], controlling or averting epidemics of HIV
infection among IDU requires minimizing the transmis-
sion of HIV within correctional environments, as well as
reducing the rate of incarceration of drug-using popula-
tions [36]. Our findings provide further evidence of the
urgent need for harm reduction measures, including
syringe exchange, in Thai prisons. Indeed, previous evalu-
ations indicate that prison-based syringe exchange pro-
grams have been successfully implemented in a range of
settings, including low- and middle-income countries
[37].
Our findings also suggest that compulsory drug treatment
experience is common among Thai IDU with a history of
incarceration. This may be due to the fact that Thai IDU
are often arrested and held within prison before being
diverted to a compulsory treatment setting. Recent reports
suggest that IDU spend on average 45 days in prison prior
to the diversion [38]. The compulsory treatment system is
intended to treat drug users as "patients" and reduce drug-
related harms in overcrowded prisons [31,39]. However,
given the evidence indicating high rates of syringe sharing
among IDU within Thai prisons in our study, as well as in
previous studies [19,34], the program of arrest and com-
pulsory drug treatment system, which requires incarcera-
tion of IDU, may fail to prevent HIV risk behavior
occurring within prisons and thus may serve to perpetuate
rather than reduce HIV infection rates among Thai IDU inBMC Public Health 2009, 9:492 http://www.biomedcentral.com/1471-2458/9/492
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Table 1: Factors associated with history of incarceration among IDU in Bangkok, Thailand (n = 252)
Characteristic History of incarceration n (%) OR 95% CI p-value
Yes: 197 (78) No: 55 (22)
Median age
< 36.5 years 100 (51) 26 (47) 1.15 0.63 - 2.09 0.647
≥ 36.5 years 97 (49) 29 (53)
Gender
Female 45 (23) 21 (38) 0.48 0.25 - 0.91 0.024
Other 152 (77) 34 (62)
Education
≥ Secondary 122 (62) 27 (49) 1.69 0.92 - 3.08 0.089
< Secondary 75 (38) 28 (51)
Median daily expenses for purchasing drugs
< 300 Thai baht 94 (48) 31 (56) 0.71 0.39 - 1.29 0.258
≥ 300Thai baht 103 (52) 24 (44)
Ever injected heroin
Yes 186 (94) 48 (87) 2.47 0.91 - 6.70 0.077
No 11 (6) 7 (13)
Ever injected yaba (methamphetamine)
Yes 128 (65) 33 (60) 1.24 0.67 - 2.28 0.497
No 69 (35) 22 (40)
Ever injected midazolam
Yes 139 (71) 30 (55) 2.00 1.08 -- 3.69 0.027
No 58 (29) 25 (45)
Ever injected methadone
Yes 33 (17) 6 (11) 1.64 0.65 - 4.15 0.293
No 164 (83) 49 (89)
Ever used drugs in combination
Yes 141 (72) 34 (62) 1.56 0.83 - 2.91 0.167
No 56 (28) 21 (38)
Ever shared syringes
Yes 107 (54) 18 (33) 2.44 1.30 - 4.58 0.005BMC Public Health 2009, 9:492 http://www.biomedcentral.com/1471-2458/9/492
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this setting. Further, the effectiveness of the current system
also comes into question given that compulsory drug
treatment often consists of a military-style boot camp
with no evidenced-based addiction treatment being
offered [38]. Taken together with our finding of a lack of
an association between incarceration and reduction in
injection drug use, our study indicates a need to reform
the existing diversion program for drug-using offenders.
Unfortunately, the evidence concerning commonly
applied diversion programs, such as drug courts, is equiv-
ocal [40], and therefore there is a need for innovation in
this area. However, as a recent report from the United
Kingdom suggested, when diversion programs are applied
within a climate shaped by draconian drug policy, such
programs tend to be punishment-oriented and inflexible
regarding individual treatment needs [41]. Therefore,
broader structural changes to the over-arching policy envi-
ronment are needed to ensure that responses to addiction
focus on the health needs of drug users rather than pun-
ishment.
We also found that non-fatal overdose was associated
with incarceration among Thai IDU. This finding is of sig-
nificance given the dearth of evidence pertaining to over-
dose among Thai IDU. While we were unable to establish
a temporal relationship between overdose and incarcera-
tion in this sample, mounting evidence from Western
countries indicates that incarceration greatly exacerbates
the risk of fatal and non-fatal overdose among IDU upon
release from prison [42-47]. In particular, risk for heroin
overdose is likely to be elevated upon release from prisons
as a result of reduced tolerance [48]. A recent study from
the US reported that drug overdose was a leading cause of
death among former inmates [44]. Further research is
No 90 (46) 37 (67)
Ever overdosed
Yes 69 (35) 6 (11) 4.40 1.80 - 10.79 0.001
No 128 (65) 49 (89)
Ever involved in sex trade
Yes 20 (10) 11 (20) 0.45 0.20 - 1.01 0.054
No 177 (90) 44 (80)
Ever in compulsory drug treatment
Yes 74 (38) 6 (11) 4.91 2.01 - 12.03 < 0.001
No 123 (62) 49 (89)
Ever on methadone treatment
Yes 89 (45) 22 (40) 1.24 0.67 - 2.27 0.494
No 108 (55) 33 (60)
Table 1: Factors associated with history of incarceration among IDU in Bangkok, Thailand (n = 252) (Continued)
Table 2: Multivariate logistic regression analysis of factors associated with reporting a history of incarceration among IDU in Bangkok, 
Thailand (n = 252)
Characteristic AOR 95% CI p-value
Gender (female vs. other) 0.41 0.20 - 0.82 0.01
Ever shared syringes (yes vs. no) 2.20 1.12 - 4.32 0.02
Ever overdosed (yes vs. no) 3.69 1.45 - 9.39 0.01
Ever in forced treatment (yes vs. no) 4.93 1.95 - 12.48 < 0.01BMC Public Health 2009, 9:492 http://www.biomedcentral.com/1471-2458/9/492
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needed to elicit the linkage between overdose and incar-
ceration among Thai IDU.
This study has several limitations. First, since this is an
observational study, we cannot infer causal relationships
between exposure and outcome. Second, the study relied
on self-report, and therefore the results may be affected by
socially desirable reporting. While the peer-administered
interviews were expected to minimize such bias, we may
still have underestimated the true prevalence of incarcera-
tion among Thai IDU or the prevalence of drug use or
syringe sharing within prisons. Third, the study sample
was not randomly recruited, which means our findings
may not be generalizable to other populations of IDU in
Thailand. Finally, we could not distinguish incarceration
histories by type, duration, or location of incarceration.
Future research should aim to address the effect that these
modifiers might have on active IDU and their risk behav-
iors.
Conclusions
We observed alarmingly high levels of incarceration and
syringe sharing in prison among a community-recruited
sample of Thai IDU. Incarceration was independently
associated with compulsory drug treatment experience,
syringe sharing and non-fatal overdose, but was not asso-
ciated with reductions in the frequency of injecting. These
findings raise serious concerns regarding the adverse
health consequences resulting from the enforcement-
based approach to illicit drug use in Thailand and under-
score the urgent need for community diversion programs
(e.g., addiction treatment) and harm reduction measures
(e.g., syringe exchange) in prisons.
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